Boehringer Ingelheim

Boehringer Ingelheim, founded in 1885, stands as a global leader in pharmaceuticals and healthcare. With a commitment to improving the health and well-being of humans and animals, the company dedicates itself to researching, developing, and producing innovative solutions across various therapeutic areas. Headquartered in Ingelheim am Rhein, Germany, Boehringer Ingelheim has steadily grown its presence worldwide, driven by a mission to deliver value through science and innovation.

Boehringer Ingelheim operates with a focus on pharmaceuticals and biopharmaceuticals, addressing critical health challenges in fields such as respiratory diseases, oncology, cardiovascular diseases, metabolism disorders, and immunology. The company also places significant emphasis on animal health, offering products that enhance the lives of pets and livestock. By leveraging advanced research and technology, the company continuously seeks to provide therapeutic breakthroughs that transform patient care and address unmet medical needs.

Guided by a vision of sustainable growth and innovation, Boehringer Ingelheim invests heavily in research and development, fostering collaborations with scientific communities and industry partners. This approach ensures the company remains at the forefront of medical advancements, contributing to a healthier future for generations to come. With over 52,000 employees globally, Boehringer Ingelheim upholds its commitment to ethical practices and corporate responsibility, striving to create a positive impact on society and the environment.